Therapeutic proteins are engineered in the laboratory for pharmaceutical use. They include non-covalent binders, enzymes and albumin and therefore have a wide range of treatment applications. Oral vaccines are biologically prepared products, which provide active acquired immunity to diseases. There are currently oral vaccines targeting cholera, polio, rotavirus, smallpox and yellow fever, among others. Oral vaccines comprise an agent resembling the disease-causing microorganism, such as a live attenuated or killed viral particle or the micro-organisms toxins or surface proteins.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Proteins and Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Proteins and Oral Vaccines. This report contains market size and forecasts of Therapeutic Proteins and Oral Vaccines in global, including the following market information:
Global Therapeutic Proteins and Oral Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Therapeutic Proteins and Oral Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Therapeutic Proteins Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Proteins and Oral Vaccines include Abbott, Amgen, Biogen, Eli Lilly and Company, Roche, Johnson and Johnson, Merck, Novo Nordisk and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Therapeutic Proteins and Oral Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Therapeutic Proteins and Oral Vaccines Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, by Type, 2022 (%)
Therapeutic Proteins
Oral Vaccines
Global Therapeutic Proteins and Oral Vaccines Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Therapeutic Proteins and Oral Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Therapeutic Proteins and Oral Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Therapeutic Proteins and Oral Vaccines revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Therapeutic Proteins and Oral Vaccines revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Amgen
Biogen
Eli Lilly and Company
Roche
Johnson and Johnson
Merck
Novo Nordisk
Pfizer
Sanofi
Serum Institute of India
Emergent Biosolutions
TransAlgae
MigVax
Lumen Bioscience
Outline of Major Chapters:
Chapter 1: Introduces the definition of Therapeutic Proteins and Oral Vaccines, market overview.
Chapter 2: Global Therapeutic Proteins and Oral Vaccines market size in revenue.
Chapter 3: Detailed analysis of Therapeutic Proteins and Oral Vaccines company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic Proteins and Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Therapeutic Proteins and Oral Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Therapeutic Proteins and Oral Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Therapeutic Proteins and Oral Vaccines Overall Market Size
2.1 Global Therapeutic Proteins and Oral Vaccines Market Size: 2022 VS 2030
2.2 Global Therapeutic Proteins and Oral Vaccines Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Therapeutic Proteins and Oral Vaccines Players in Global Market
3.2 Top Global Therapeutic Proteins and Oral Vaccines Companies Ranked by Revenue
3.3 Global Therapeutic Proteins and Oral Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Therapeutic Proteins and Oral Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Therapeutic Proteins and Oral Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Therapeutic Proteins and Oral Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Therapeutic Proteins and Oral Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Therapeutic Proteins and Oral Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Therapeutic Proteins and Oral Vaccines Market Size Markets, 2022 & 2030
4.1.2 Therapeutic Proteins
4.1.3 Oral Vaccines
4.2 By Type - Global Therapeutic Proteins and Oral Vaccines Revenue & Forecasts
4.2.1 By Type - Global Therapeutic Proteins and Oral Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Therapeutic Proteins and Oral Vaccines Revenue, 2024-2030
4.2.3 By Type - Global Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Therapeutic Proteins and Oral Vaccines Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Therapeutic Proteins and Oral Vaccines Revenue & Forecasts
5.2.1 By Application - Global Therapeutic Proteins and Oral Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Therapeutic Proteins and Oral Vaccines Revenue, 2024-2030
5.2.3 By Application - Global Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Therapeutic Proteins and Oral Vaccines Market Size, 2022 & 2030
6.2 By Region - Global Therapeutic Proteins and Oral Vaccines Revenue & Forecasts
6.2.1 By Region - Global Therapeutic Proteins and Oral Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Therapeutic Proteins and Oral Vaccines Revenue, 2024-2030
6.2.3 By Region - Global Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Therapeutic Proteins and Oral Vaccines Revenue, 2018-2030
6.3.2 US Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.3.3 Canada Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.3.4 Mexico Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Therapeutic Proteins and Oral Vaccines Revenue, 2018-2030
6.4.2 Germany Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.4.3 France Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.4.4 U.K. Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.4.5 Italy Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.4.6 Russia Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.4.7 Nordic Countries Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.4.8 Benelux Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Therapeutic Proteins and Oral Vaccines Revenue, 2018-2030
6.5.2 China Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.5.3 Japan Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.5.4 South Korea Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.5.5 Southeast Asia Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.5.6 India Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Therapeutic Proteins and Oral Vaccines Revenue, 2018-2030
6.6.2 Brazil Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.6.3 Argentina Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue, 2018-2030
6.7.2 Turkey Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.7.3 Israel Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.7.4 Saudi Arabia Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
6.7.5 UAE Therapeutic Proteins and Oral Vaccines Market Size, 2018-2030
7 Therapeutic Proteins and Oral Vaccines Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.1.4 Abbott Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.2.4 Amgen Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Biogen
7.3.1 Biogen Company Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.3.4 Biogen Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.3.5 Biogen Key News & Latest Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.4.4 Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.4.5 Eli Lilly and Company Key News & Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.5.4 Roche Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.5.5 Roche Key News & Latest Developments
7.6 Johnson and Johnson
7.6.1 Johnson and Johnson Company Summary
7.6.2 Johnson and Johnson Business Overview
7.6.3 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.6.4 Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.6.5 Johnson and Johnson Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.7.4 Merck Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Novo Nordisk
7.8.1 Novo Nordisk Company Summary
7.8.2 Novo Nordisk Business Overview
7.8.3 Novo Nordisk Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.8.4 Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.8.5 Novo Nordisk Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.9.4 Pfizer Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
7.10 Sanofi
7.10.1 Sanofi Company Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.10.4 Sanofi Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.10.5 Sanofi Key News & Latest Developments
7.11 Serum Institute of India
7.11.1 Serum Institute of India Company Summary
7.11.2 Serum Institute of India Business Overview
7.11.3 Serum Institute of India Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.11.4 Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.11.5 Serum Institute of India Key News & Latest Developments
7.12 Emergent Biosolutions
7.12.1 Emergent Biosolutions Company Summary
7.12.2 Emergent Biosolutions Business Overview
7.12.3 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.12.4 Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.12.5 Emergent Biosolutions Key News & Latest Developments
7.13 TransAlgae
7.13.1 TransAlgae Company Summary
7.13.2 TransAlgae Business Overview
7.13.3 TransAlgae Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.13.4 TransAlgae Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.13.5 TransAlgae Key News & Latest Developments
7.14 MigVax
7.14.1 MigVax Company Summary
7.14.2 MigVax Business Overview
7.14.3 MigVax Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.14.4 MigVax Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.14.5 MigVax Key News & Latest Developments
7.15 Lumen Bioscience
7.15.1 Lumen Bioscience Company Summary
7.15.2 Lumen Bioscience Business Overview
7.15.3 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Major Product Offerings
7.15.4 Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue in Global Market (2018-2023)
7.15.5 Lumen Bioscience Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Therapeutic Proteins and Oral Vaccines Market Opportunities & Trends in Global Market
Table 2. Therapeutic Proteins and Oral Vaccines Market Drivers in Global Market
Table 3. Therapeutic Proteins and Oral Vaccines Market Restraints in Global Market
Table 4. Key Players of Therapeutic Proteins and Oral Vaccines in Global Market
Table 5. Top Therapeutic Proteins and Oral Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Therapeutic Proteins and Oral Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Therapeutic Proteins and Oral Vaccines Revenue Share by Companies, 2018-2023
Table 8. Global Companies Therapeutic Proteins and Oral Vaccines Product Type
Table 9. List of Global Tier 1 Therapeutic Proteins and Oral Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Therapeutic Proteins and Oral Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Therapeutic Proteins and Oral Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Therapeutic Proteins and Oral Vaccines Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Therapeutic Proteins and Oral Vaccines Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Therapeutic Proteins and Oral Vaccines Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Company Summary
Table 31. Abbott Therapeutic Proteins and Oral Vaccines Product Offerings
Table 32. Abbott Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Therapeutic Proteins and Oral Vaccines Product Offerings
Table 36. Amgen Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 37. Amgen Key News & Latest Developments
Table 38. Biogen Company Summary
Table 39. Biogen Therapeutic Proteins and Oral Vaccines Product Offerings
Table 40. Biogen Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 41. Biogen Key News & Latest Developments
Table 42. Eli Lilly and Company Company Summary
Table 43. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Product Offerings
Table 44. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 45. Eli Lilly and Company Key News & Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Therapeutic Proteins and Oral Vaccines Product Offerings
Table 48. Roche Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 49. Roche Key News & Latest Developments
Table 50. Johnson and Johnson Company Summary
Table 51. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Product Offerings
Table 52. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson and Johnson Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Therapeutic Proteins and Oral Vaccines Product Offerings
Table 56. Merck Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 57. Merck Key News & Latest Developments
Table 58. Novo Nordisk Company Summary
Table 59. Novo Nordisk Therapeutic Proteins and Oral Vaccines Product Offerings
Table 60. Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 61. Novo Nordisk Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Therapeutic Proteins and Oral Vaccines Product Offerings
Table 64. Pfizer Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Sanofi Company Summary
Table 67. Sanofi Therapeutic Proteins and Oral Vaccines Product Offerings
Table 68. Sanofi Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 69. Sanofi Key News & Latest Developments
Table 70. Serum Institute of India Company Summary
Table 71. Serum Institute of India Therapeutic Proteins and Oral Vaccines Product Offerings
Table 72. Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 73. Serum Institute of India Key News & Latest Developments
Table 74. Emergent Biosolutions Company Summary
Table 75. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Product Offerings
Table 76. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 77. Emergent Biosolutions Key News & Latest Developments
Table 78. TransAlgae Company Summary
Table 79. TransAlgae Therapeutic Proteins and Oral Vaccines Product Offerings
Table 80. TransAlgae Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 81. TransAlgae Key News & Latest Developments
Table 82. MigVax Company Summary
Table 83. MigVax Therapeutic Proteins and Oral Vaccines Product Offerings
Table 84. MigVax Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 85. MigVax Key News & Latest Developments
Table 86. Lumen Bioscience Company Summary
Table 87. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Product Offerings
Table 88. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue (US$, Mn) & (2018-2023)
Table 89. Lumen Bioscience Key News & Latest Developments
List of Figures
Figure 1. Therapeutic Proteins and Oral Vaccines Segment by Type in 2022
Figure 2. Therapeutic Proteins and Oral Vaccines Segment by Application in 2022
Figure 3. Global Therapeutic Proteins and Oral Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Therapeutic Proteins and Oral Vaccines Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Therapeutic Proteins and Oral Vaccines Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Therapeutic Proteins and Oral Vaccines Revenue in 2022
Figure 8. By Type - Global Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 9. By Application - Global Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 10. By Type - Global Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 12. By Application - Global Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 14. By Region - Global Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 15. By Country - North America Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 16. US Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 20. Germany Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 21. France Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 28. China Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 32. India Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 34. Brazil Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Therapeutic Proteins and Oral Vaccines Revenue Market Share, 2018-2030
Figure 37. Turkey Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Therapeutic Proteins and Oral Vaccines Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Amgen Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biogen Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Eli Lilly and Company Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Roche Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson and Johnson Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Merck Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Novo Nordisk Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sanofi Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Serum Institute of India Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Emergent Biosolutions Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. TransAlgae Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. MigVax Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Lumen Bioscience Therapeutic Proteins and Oral Vaccines Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
